Yunnan Peak Starts Safety Production Standardization Re-evaluation Work
Release time:
2020-07-22
Yunnan Jianfeng Starts Re-evaluation of Safety Production Standardization
News In order to implement the new "Safety Production Law" and the new "Safety Standard " requirements and consolidate the achievements of safety production standardization, Yunnan Jianfeng Cement Company recently held a kick-off meeting for safety production standardization re-evaluation, Yunnan peak safety production standardization secondary re-evaluation work officially launched.
This safety standard review is carried out under the guidance of Yunnan superstar registered safety engineer firm co., ltd. At the first consultation meeting, the expert group affirmed the achievements made by Yunnan Jianfeng in promoting safety standardization, introduced the contents of new safety laws and regulations, interpreted and trained the basic knowledge, detailed requirements and safety standard concept of new safety production standardization, emphasized the requirements of safety standardization, listed the problems existing in the production site, and put forward specific rectification opinions. After the
consultation meeting, according to expert opinions, Yunnan peak production site hardware facilities and software data, basic management, equipment, electrical, mechanical, thermal explosion, operating environment and other rapid start-up procedures, according to the safety standardization requirements to formulate a detailed implementation plan, the current work is in an orderly progress.
The establishment of Yunnan Peak Safety Production Standardization Level 3 Enterprise began at the beginning of 2015 , obtained the Building Materials and Cement Safety Production Standardization Level 3 Enterprise Certificate on 2016 4 19 , and obtained the Building Materials and Cement Safety Production Standardization Level 2 Enterprise Certificate on 2017 12 20 . After three years of continuous operation, a good safety management mechanism has been formed. At present, Yunnan Jianfeng has established a relatively complete safety management system, and various tasks such as safety hazard investigation, hazard source control, on-site 6S management, labor protection, occupational health examination and hazard factor detection have been gradually standardized, and the production environment has also been improved year by year., The level of safety management has been continuously improved, and the standardization of safety production has achieved remarkable results.
Zhou Jiping, general manager of Yunnan Jianfeng, requested at the meeting that all departments strengthen the basic work of safety production in Yunnan Jianfeng through safety production standardization work, and promote enterprises to establish a long-term safety production mechanism with self-restraint and continuous improvement to better Complete production and operation tasks; all employees must actively participate in safety production standardization work and make their own contributions to ensure that they pass the review at the end of the year.
4 April 16 and 17 , Yunnan Jianfeng also specially invited experts from Yunnan superstar registered safety engineer co., ltd. to carry out safety production standardization re-evaluation publicity and guidance training, mainly focusing on hardware facilities and software data, of which hardware facilities are divided into electrical auxiliary equipment facilities group and equipment technology, etc, from the data, the scene and other aspects of a full range of inspection, guidance. At the same time, suggestions and rectification measures are put forward for the existing problems and deficiencies, and the responsible person for rectification is determined and safety measures are implemented. ( Liu Fengbin )
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31